Document Detail


Retinopathy screening in individuals with type 2 diabetes: who, how, how often, and at what cost--an epidemiologic review.
MedLine Citation:
PMID:  16298316     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
BACKGROUND: Despite treatment regimens, which can reduce blindness, diabetic retinopathy remains the leading cause of irreversible blindness for persons less than 75 years. Screening for diabetic retinopathy in type 1 diabetes mellitus has proven to be both efficacious and cost effective. Although treatment has been shown to be equally efficacious for type 2 diabetes, the effectiveness and cost benefit of screening are less clear. METHODS: A systematic review of the recent literature on the epidemiology of retinopathy in type 2 diabetics was carried out. Specific issues related to the changing epidemiology of diabetes and diabetic retinopathy, as well as the effectiveness, and cost benefit of screening were evaluated. CONCLUSIONS: Diabetic retinopathy is at the convergence of several epidemiologic trends. Although the prevalence of diabetic retinopathy within the population of diagnosed diabetics may be decreasing because of aggressive risk factor reduction, any gains achieved are likely to be negated by the large increase in the prevalence of type 2 diabetes in the population owing to obesity. The epidemiology findings suggest that certain persons with well-controlled type 2 diabetes may not warrant yearly examination for diabetic retinopathy; however, given the low percentage of diabetics who are currently screened for retinopathy, it would seem unwise to recommend changes in the timing of examination. Evidence appears to suggest that photoscreening is a viable alternative to a screening examination.
Authors:
Mark Swanson
Related Documents :
16678516 - Hemoglobin a1c awareness among patients receiving eye care at a tertiary ophthalmic cen...
3536206 - Diabetic retinopathy: current concepts of evaluation and treatment.
3867906 - Limited joint mobility in insulin-dependent diabetes: relationship to retinopathy, peri...
16444186 - Somatostatin in diabetic retinopathy.
24781986 - Chemokine-like receptor 1 deficiency does not affect the development of insulin resista...
24374946 - Pattern of use of complementary and alternative medicine among type 2 diabetes mellitus...
Publication Detail:
Type:  Journal Article; Review    
Journal Detail:
Title:  Optometry (St. Louis, Mo.)     Volume:  76     ISSN:  1529-1839     ISO Abbreviation:  Optometry     Publication Date:  2005 Nov 
Date Detail:
Created Date:  2005-11-21     Completed Date:  2006-01-26     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  100912421     Medline TA:  Optometry     Country:  United States    
Other Details:
Languages:  eng     Pagination:  636-46     Citation Subset:  IM    
Affiliation:
University of Alabama, School of Optometry, Birmingham, Alabama 35294-0010, USA. MSwanson@icare.opt.uab.edu
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Cost-Benefit Analysis
Diabetes Mellitus, Type 2 / complications*
Diabetic Retinopathy / economics*,  etiology,  prevention & control*
Health Care Costs
Humans
Incidence
Mass Screening / economics*
World Health

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Plastic bronchitis: new insights and a classification scheme.
Next Document:  The effect of laser refractive surgery on the on-field performance of professional baseball players.